gracecast-111_lung-cancer_asco 2012 lc highlights: dr. socinski on tailor trial in advanced nsclc
Published 11 years ago • 208 plays • Length 7:09Download video MP4
Download video MP3
Similar videos
-
8:06
gracecast-112_lung-cancer_asco 2012 lc highlights: dr. socinski on key trials in small cell lc
-
6:50
gracecast-110_lung-cancer_asco 2012 lc highlights: dr. socinski on single agent vs doublet chemo
-
8:38
gracecast-109_lung-cancer_asco 2012 lung cancer highlights: dr. mark socinski on paramount trial
-
5:11
gracecast-114_lung-cancer_asco 2012 lc highlights: dr. neal on mek inhibitor selumetinib in nsclc
-
5:13
gracecast-115_lung-cancer_asco 2012 lc highlights: dr. neal on lux-lung 3 trial for advanced nsclc
-
20:34
gracecast-118_lung-cancer_asco 2012 lung cancer highlights: question and answer session
-
4:51
gracecast-116_lung-cancer_asco 2012 lc highlights: dr. neal on select trial of tarceva (erlotinib)
-
4:30
gracecast-117_lung-cancer_asco 2012 lc highlights: dr. neal on molecular targets in squamous nsclc
-
23:32
gracecast-077_lung-cancer_asco 2011 highlights - advanced/metastatic nsclc
-
11:13
gracecast-091_lung-cancer_highlights 2011: the egfr axis
-
10:37
gracecast-141_lung_highlights in lung cancer, 2012: alk inhibitors for patients with alk or ros1
-
15:53
gracecast-054_lung-cancer_socinski on advanced nsclc maintenance therapy q&a
-
40:09
gracecast-076_lung-cancer_asco 2011 highlights - sclc, early stage nsclc and mesothelioma
-
9:49
gracecast-001_lung-cancer_first line chemo for advanced nscl
-
10:03
gracecast-011_lung-cancer_second line treatment for nsclc
-
10:43
gracecast-007_lung-cancer_optimal treatment of unresectable locally advanced nsclc
-
40:44
gracecast-050_lung-cancer_ramalingam on first line therapy for advanced nsclc
-
12:33
gracecast-025_lung-cancer_questions and trials for nsclc
-
36:41
gracecast-053_lung-cancer_socinski on advanced nsclc maintenance therapy